Advertisement

Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales

  • V. J. ChalkerEmail author
  • T. Stocki
  • M. Mentasti
  • D. Fleming
  • C. Sadler
  • J. Ellis
  • A. Bermingham
  • T. G. Harrison
Article

Abstract

Real-time PCR was employed to detect a conserved region of the P1 cytadhesin gene of Mycoplasma pneumoniae in combined nose and throat swabs collected from patients attending GP surgeries during 2005–2009 with symptoms of respiratory tract infection (RTI). Samples were collected as part of an annual winter epidemiological and virological linked study in England and Wales. A total of 3,987 samples were tested, 65 (1.7%, 95%CI 1.3–2.1) had detectable M. pneumoniae DNA. Positive patients were detected of both gender, aged from 9 months to 78 years, who had clinical signs of upper RTI, fever and/or myalgia, an influenza-like illness to lower RTI. Mixed infections were identified in four cases, two with influenza A H1, one with H3 and one with influenza B. Children aged 5–14 years were more likely to have detectable M. pneumoniae in samples than all other age groups (Fishers p = 0.03), attributed to the 2005–2006 season in which 6.0% (12/200, 95%CI 3.4–10.3) of 5–14 year olds had detectable M. pneumoniae in comparison to 2.2% in 2006–2007 (3/141 95%CI 0.5–6.4), 2.2% in 2007–2008 (2/89 95%CI 0.1–8.3) and 0% in 2008-2009 (0/151 95%CI 0–2.9).

Keywords

Influenza Respiratory Syncytial Virus Mixed Infection Respiratory Syncytial Virus Infection Mycoplasma Pneumoniae 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors would like to thank the Birmingham Research Unit of the Royal College of General Practitioners, the HPA Surveillance of Influenza Group, CDSC HPA for Fig. 1, Tony McNiff for IT assistance, and Carmen Sheppard and Catherine Brown for Hertfordshire carriage data.

References

  1. 1.
    British Thoracic Society (2002) BTS guidelines for the management of community acquired pneumonia in childhood. Thorax 57:1–24CrossRefGoogle Scholar
  2. 2.
    Clyde WA (1993) Clinical Overview of typical M. pneumoniae infections. Clin Infect Dis 17(Suppl 3):S32–S36PubMedGoogle Scholar
  3. 3.
    Creer DD, Dilworth JP, Gillespie SH, Johnston AR, Johnston SL, Ling C, Patel S, Sanderson G, Wallace PG, McHugh TD (2006) Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax 61:75–79PubMedCrossRefGoogle Scholar
  4. 4.
    Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, Cirillo C, Di Pietro P, Rossi GA (2008) Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 102:1762–1768PubMedCrossRefGoogle Scholar
  5. 5.
    Ellis JS, Fleming DM, Zambon MC (1997) Multiplex reverse transcription–PCR for surveillance of Influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol 35:2076–2082PubMedGoogle Scholar
  6. 6.
    Ferwerda A, Moll HA, de Groot R (2001) Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 160:483–491PubMedCrossRefGoogle Scholar
  7. 7.
    Fleming DM, Ross AM, Cross KW, Kendall H (2003) The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 53:778–783PubMedGoogle Scholar
  8. 8.
    Fleming DM, Elliot AJ (2008) Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect 136:866–875PubMedCrossRefGoogle Scholar
  9. 9.
    Foy HM (1993) Infections caused by M. pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17(Suppl 1):S37–S46PubMedCrossRefGoogle Scholar
  10. 10.
    Gnarpe J, Lundback A, Sundelof B, Gnarpe H (1992) Prevalence of M. pneumoniae in subjectively healthy individuals. Scand J Infect Dis 24:161–164PubMedCrossRefGoogle Scholar
  11. 11.
    Howard LS, Sillis M, Pasteur MC, Kamath AV, Harrison BD (2005) Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect 50:107–113PubMedCrossRefGoogle Scholar
  12. 12.
    Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, Talukdar R, Martin SA, Efstratiou A, Miller E (2005) A longitudinal household study of S. pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 133:891–898PubMedCrossRefGoogle Scholar
  13. 13.
    Kleemola M, Jokinen C (1992) Outbreak of M. pneumoniae infection among hospital personnel studied by a nucleic acid hybridization test. J Hosp Infect 21:213–221PubMedCrossRefGoogle Scholar
  14. 14.
    Layani-Milon MP, Gras I, Valette M, Luciani J, Stagnara J, Aymard M, Lina B (1999) Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. J Clin Microbiol 37:1721–1726PubMedGoogle Scholar
  15. 15.
    Longo MC, Berninger MS, Hartley JL (1990) Use of uracil DNA glycosylate to control carry-over in polymerase chain reaction. Gene 93:125–128PubMedCrossRefGoogle Scholar
  16. 16.
    Nilsson AC, Björkman P, Welinder-Olsson C, Widell A, Persson K (2010) Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis 25:10–39Google Scholar
  17. 17.
    Pitcher D, Chalker VJ, Sheppard C, George RC, Harrison TG (2006) Real-time detection of M. pneumoniae in respiratory samples with an internal processing control. J Med Microbiol 55:149–155PubMedCrossRefGoogle Scholar
  18. 18.
    Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M (2009) Neuraminidase resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis 48:389–396PubMedCrossRefGoogle Scholar
  19. 19.
    Vervloet LA, Marguet C, Camargos PA (2007) Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz J Infect Dis 11:507–514PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • V. J. Chalker
    • 1
    Email author
  • T. Stocki
    • 1
  • M. Mentasti
    • 1
  • D. Fleming
    • 2
  • C. Sadler
    • 3
  • J. Ellis
    • 3
  • A. Bermingham
    • 3
  • T. G. Harrison
    • 1
  1. 1.Respiratory and Systemic Infection LaboratoryHealth Protection Agency Centre for InfectionsLondonUK
  2. 2.Birmingham Research Unit of the Royal College of General PractitionersBirminghamUK
  3. 3.Viral Reference DepartmentHealth Protection Agency Centre for InfectionsLondonUK

Personalised recommendations